ID

34291

Beschreibung

A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01999322

Link

https://clinicaltrials.gov/show/NCT01999322

Stichworte

  1. 16.01.19 16.01.19 -
Rechteinhaber

see on clinicaltrials.gov

Hochgeladen am

16. Januar 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes NCT01999322

Eligibility Diabetes NCT01999322

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01999322
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female, age at least 18 years at the time of signing inform consent
Beschreibung

ID.1

Datentyp

boolean

type 1 diabetes mellitus (diagnosed clinically) for at least 12 months at the time of screening (visit 1)
Beschreibung

ID.2

Datentyp

boolean

currently treated with insulin aspart, insulin lispro or insulin gluisine for at least 3 months prior to screening (visit 1)
Beschreibung

ID.3

Datentyp

boolean

using an external csii system for the previous 6 months prior to screening (visit 1)
Beschreibung

ID.4

Datentyp

boolean

hba1c (glycosylated haemoglobin) below or equal to 9.0% as assessed by central laboratory
Beschreibung

ID.5

Datentyp

boolean

body mass index (bmi) 20.0-35.0 kg/m^2
Beschreibung

ID.6

Datentyp

boolean

Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of diabetic ketoacidosis (dka) episodes requiring hospitalization within 6 months prior to screening (visit 1)
Beschreibung

ID.7

Datentyp

boolean

history of abscess at the infusion site within 6 months prior to screening (visit 1)
Beschreibung

ID.8

Datentyp

boolean

hypoglycaemic unawareness as judged by the investigator or history of severe hypoglycaemic episodes requiring hospitalization within the last 6 months prior to screening (visit 1)
Beschreibung

ID.9

Datentyp

boolean

Ähnliche Modelle

Eligibility Diabetes NCT01999322

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01999322
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
male or female, age at least 18 years at the time of signing inform consent
boolean
ID.2
Item
type 1 diabetes mellitus (diagnosed clinically) for at least 12 months at the time of screening (visit 1)
boolean
ID.3
Item
currently treated with insulin aspart, insulin lispro or insulin gluisine for at least 3 months prior to screening (visit 1)
boolean
ID.4
Item
using an external csii system for the previous 6 months prior to screening (visit 1)
boolean
ID.5
Item
hba1c (glycosylated haemoglobin) below or equal to 9.0% as assessed by central laboratory
boolean
ID.6
Item
body mass index (bmi) 20.0-35.0 kg/m^2
boolean
Item Group
C0680251 (UMLS CUI)
ID.7
Item
history of diabetic ketoacidosis (dka) episodes requiring hospitalization within 6 months prior to screening (visit 1)
boolean
ID.8
Item
history of abscess at the infusion site within 6 months prior to screening (visit 1)
boolean
ID.9
Item
hypoglycaemic unawareness as judged by the investigator or history of severe hypoglycaemic episodes requiring hospitalization within the last 6 months prior to screening (visit 1)
boolean

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video